Pinar Topsever

Acibadem, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuum.

CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuum.

Journal: Cardiovascular diabetology

Published: January 26, 2026

From global guidelines for cardio-kidney-metabolic diseases management to national implementation: perspectives from the guideline workshop taskforce.

From global guidelines for cardio-kidney-metabolic diseases management to national implementation: perspectives from the guideline workshop taskforce.

Journal: Cardiovascular diabetology

Published: December 03, 2025

CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes.

CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes.

Journal: Cardiovascular diabetology

Published: February 18, 2025

The use of continuous glucose monitoring in people living with obesity, intermediate hyperglycemia or type 2 diabetes.

The use of continuous glucose monitoring in people living with obesity, intermediate hyperglycemia or type 2 diabetes.

Journal: Diabetes research and clinical practice

Published: February 17, 2025

Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop.

Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop.

Journal: Cardiovascular diabetology

Published: November 08, 2024

CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes.

CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes.

Journal: Cardiovascular diabetology

Published: February 20, 2024

Disparities in prevalence and treatment of diabetes, cardiovascular and chronic kidney diseases - Recommendations from the taskforce of the guideline workshop.

Disparities in prevalence and treatment of diabetes, cardiovascular and chronic kidney diseases - Recommendations from the taskforce of the guideline workshop.

Journal: Diabetes research and clinical practice

Published: February 07, 2024

Associations of blood pressure with cardiovascular and mortality outcomes in over 2 million older persons with or without diabetes mellitus: A systematic review and meta-analysis of 45 cohort studies.

Associations of blood pressure with cardiovascular and mortality outcomes in over 2 million older persons with or without diabetes mellitus: A systematic review and meta-analysis of 45 cohort studies.

Journal: Primary care diabetes

Published: July 08, 2023

CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes.

CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes.

Journal: Cardiovascular diabetology

Published: February 07, 2023

Self-rated knowledge and competence regarding the management of chronic kidney disease in primary care: A cross-sectional European survey of primary care professionals.

Self-rated knowledge and competence regarding the management of chronic kidney disease in primary care: A cross-sectional European survey of primary care professionals.

Journal: Primary care diabetes

Published: November 02, 2022

Benefits and harms of sodium-glucose co-transporter-2 inhibitors (SGLT2-I) and renin-angiotensin-aldosterone system inhibitors (RAAS-I) versus SGLT2-Is alone in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.

Benefits and harms of sodium-glucose co-transporter-2 inhibitors (SGLT2-I) and renin-angiotensin-aldosterone system inhibitors (RAAS-I) versus SGLT2-Is alone in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.

Journal: Endocrinology, diabetes & metabolism

Published: August 27, 2021

2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care.

2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care.

Journal: Primary care diabetes

Published: June 29, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026